SCHEMBL1460157

SCHEMBL1460157

Brn1c(C2CCCCC2)cc2ccccc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
POLB P06746 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
THRB P10828 1/20 0.36
LCK P06239 1/20 0.36
NR1I2 O75469 1/20 0.35
KDM4B O94953 1/20 0.35
CHRM1 P11229 1/20 0.35
TBXA2R P21731 1/20 0.35
ADRA1A P35348 1/20 0.35
DOHH Q9BU89 1/20 0.35
TSHR P16473 2/20 0.35
HSD17B10 Q99714 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
ALOX15 P16050 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28620587 0.79 PROKR1 (0.48) MEN1KMT2APOLBSMN1; SMN2KDM4E
SCHEMBL29188510 0.77 LCK (0.35) MEN1KMT2APOLBSMN1; SMN2KDM4E
SCHEMBL8248877 0.76 NR1I2 (0.36) MEN1KMT2APOLBSMN1; SMN2KDM4E
SCHEMBL13425054 0.76 DRD1 (0.38) SMN1; SMN2ALDH1A1LCKTSHRCNR2
SCHEMBL13425053 0.73 ALDH1A1 (0.38) SMN1; SMN2ALDH1A1TSHRCNR2LMNA
SCHEMBL15971194 0.73 CNR2 (0.41) MEN1KMT2APOLBSMN1; SMN2KDM4E
SCHEMBL11557939 0.69 TMEM97 (0.48) CNR2LMNA
SCHEMBL18990791 0.69 POLB (0.60) MEN1KMT2APOLBSMN1; SMN2KDM4E
SCHEMBL11556885 0.69 TMEM97 (0.48) CNR2LMNA
SCHEMBL17522468 0.69 KMT2A (0.47) MEN1KMT2AKDM4EALDH1A1PROKR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2480529-A1 INDOLE DERIVATIVES AS CRAC MODULATORS F. Hoffmann-La Roche AG (CH) 2012-08-01 EP disclosed
CN-102574788-A Indole derivatives as crac modulators HOFFMANN LA ROCHE 2012-07-11 CN disclosed
WO-2011036130-A1 INDOLE DERIVATIVES AS CRAC MODULATORS F. HOFFMANN-LA ROCHE AG (CH) 2011-03-31 WO disclosed
US-20110071150-A1 INDOLE DERIVATIVES AS CRAC MODULATORS ALAM MUZAFFAR 2011-03-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110071150-A1 INDOLE DERIVATIVES AS CRAC MODULATORS ORAI1, RYR2, CACNA1E MEN1 1809/4885KMT2A 4184/4885POLB 4868/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.